Mechanism of Insulin Overdose-Induced Hypothermia
Insulin overdose causes hypothermia primarily through hypoglycemia-induced metabolic suppression and adaptive thermoregulatory responses mediated by nitric oxide and carbon monoxide pathways in the central nervous system.
The Direct Connection
The link between insulin overdose and hypothermia operates through several interconnected mechanisms:
Primary Mechanism: Hypoglycemia-Induced Metabolic Changes
When insulin overdose occurs, the resulting severe hypoglycemia triggers a protective hypothermic response. This hypothermia is actually a critical survival mechanism - research demonstrates that preventing hypothermia during prolonged hypoglycemia is fatal, while allowing hypothermia enables survival 1. In experimental models, animals maintained at normal temperature during severe hypoglycemia (25-40 mg/dL) died within 7 hours, whereas those allowed to become hypothermic (dropping to ~31°C) survived and recovered fully once euglycemia was restored 1.
Neurochemical Mediators
The hypothermic response is mediated by specific pathways in the brain:
Nitric oxide (NO) pathway: NO plays a key role in insulin-induced hypothermia. When NO synthase is blocked centrally, insulin-induced hypothermia is completely prevented 2. This suggests NO is essential for the thermoregulatory response to hypoglycemia.
Carbon monoxide (CO) pathway: The haem oxygenase-CO system modulates the severity of hypothermia. Blocking this pathway actually worsens insulin-induced hypothermia, while CO administration reduces it 3. This indicates the HO-CO pathway serves as a protective brake preventing excessive temperature drops.
Clinical Manifestations
In insulin overdose, you'll observe:
- Progressive temperature decline correlating with hypoglycemia severity
- Reduced spontaneous activity as body temperature drops
- Maintained consciousness initially (unlike other causes of hypothermia) until severe stages
- Temperature nadirs typically around 31°C in experimental models 1
Important Clinical Caveats
The hypothermia itself is protective, not pathologic - it reduces metabolic demand during glucose deprivation 1. However, this creates a clinical pitfall: aggressive rewarming without correcting hypoglycemia may worsen outcomes by increasing metabolic demands that cannot be met.
The standard management priorities remain unchanged per FDA labeling: treat the hypoglycemia first with oral glucose for mild cases, or intramuscular/subcutaneous glucagon or concentrated IV glucose for severe cases with neurologic impairment 4. The hypothermia will resolve as euglycemia is restored.
Hyperinsulinemia without hypoglycemia can also trigger hypothermia through serotonergic system interactions 5, though this is less common and represents a distinct mechanism from acute overdose scenarios.
In chronic hyperinsulinemic states (like experimental obesity models), sustained hypothermia occurs even with adequate glucose, suggesting insulin has direct thermoregulatory effects beyond its glucose-lowering actions 6.